Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases

BACKGROUND: To determine the clinical benefits of systemic targeted agents across multiple histologies after stereotactic radiosurgery (SRS) for brain metastases. METHODS: Between 2000 and 2013, 737 patients underwent upfront SRS for brain metastases. Patients were stratified by whether or not they...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Adam G., Ruiz, Jimmy, Hughes, Ryan, Page, Brandi R., Isom, Scott, Lucas, John T., McTyre, Emory R., Houseknecht, Kristin W., Ayala-Peacock, Diandra N., Bourland, Daniel J., Hinson, William H., Laxton, Adrian W., Tatter, Stephen B., Debinski, Waldemar, Watabe, Kounosuke, Chan, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662466/
https://www.ncbi.nlm.nih.gov/pubmed/26087184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662466/
https://www.ncbi.nlm.nih.gov/pubmed/26087184

Ejemplares similares